ENGN · Company research
enGene Therapeutics Inc. (ENGN): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
14records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Two urologists will discuss how doctors make treatment decisions for high-risk bladder cancer. - Stock Titan | Two urologists will discuss how doctors make treatment decisions for high-risk bladder cancer. Stock Titan | View source ↗ | Stock Titan | Oct 13, 2026 | neutral | 0 | 0.6 |
| At $1.97 a share, enGene Therapeutics (ENGN) interim medical chief bought 5,102 shares. - Stock Titan | At $1.97 a share, enGene Therapeutics (ENGN) interim medical chief bought 5,102 shares. Stock Titan | View source ↗ | Stock Titan | Sep 24, 2026 | neutral | 0 | 0.6 |
| ENGN Forecast — Price Target — Prediction for 2027 - TradingView | ENGN Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| enGene Therapeutics: The Market Overreacted To The Latest Trial Results (NASDAQ:ENGN) - Seeking Alpha | enGene Therapeutics: The Market Overreacted To The Latest Trial Results (NASDAQ:ENGN) Seeking Alpha | View source ↗ | Seeking Alpha | Jun 8, 2026 | neutral | 0 | 0.6 |
| Unusual volume stocks are being observed in Monday's session. - ChartMill | Unusual volume stocks are being observed in Monday's session. ChartMill | View source ↗ | ChartMill | May 11, 2026 | neutral | 0 | 0.6 |
| A Look At enGene Therapeutics (ENGN) Valuation After LEGEND Trial Update And Legal Investigations - Yahoo Finance | A Look At enGene Therapeutics (ENGN) Valuation After LEGEND Trial Update And Legal Investigations Yahoo Finance | View source ↗ | Yahoo Finance | May 10, 2026 | neutral | 0 | 0.6 |
| StockWatch: enGene Shares Crater on Declines in Complete Response Rates to Bladder Cancer Therapy - Genetic Engineering and Biotechnology News | StockWatch: enGene Shares Crater on Declines in Complete Response Rates to Bladder Cancer Therapy Genetic Engineering and Biotechnology News | View source ↗ | Genetic Engineering and Biotechnology News | May 10, 2026 | neutral | 0 | 0.6 |
| enGene Therapeutics Inc. - Common Stock (ENGN) Stock Price, News, Quote & History - FinancialContent | enGene Therapeutics Inc. - Common Stock (ENGN) Stock Price, News, Quote & History FinancialContent | View source ↗ | FinancialContent | May 8, 2026 | neutral | 0 | 0.6 |
| ENGN Stock Collapses As Street Slashes Targets After Trial Shock - StocksToTrade | ENGN Stock Collapses As Street Slashes Targets After Trial Shock StocksToTrade | View source ↗ | StocksToTrade | May 8, 2026 | neutral | 0 | 0.6 |
| Why Is enGene Therapeutics Stock Falling Friday? - enGene Therapeutics (NASDAQ:ENGN) - Benzinga | Why Is enGene Therapeutics Stock Falling Friday? - enGene Therapeutics (NASDAQ:ENGN) Benzinga | View source ↗ | Benzinga | May 8, 2026 | neutral | 0 | 0.6 |
| enGene Therapeutics (ENGN) Is Down 76.3% After Mixed LEGEND Phase 2 Durability Data Release Has The Bull Case Changed? - Yahoo Finance | enGene Therapeutics (ENGN) Is Down 76.3% After Mixed LEGEND Phase 2 Durability Data Release Has The Bull Case Changed? Yahoo Finance | View source ↗ | Yahoo Finance | May 8, 2026 | neutral | 0 | 0.6 |
| ENGN Stock Volatile As Traders Track Liquidity And Runway - www.timothysykes.com | ENGN Stock Volatile As Traders Track Liquidity And Runway www.timothysykes.com | View source ↗ | www.timothysykes.com | May 7, 2026 | neutral | 0 | 0.6 |
| enGene Therapeutics (Nasdaq:ENGN) - Stock Analysis - Simply Wall Street | enGene Therapeutics (Nasdaq:ENGN) - Stock Analysis Simply Wall Street | View source ↗ | Simply Wall Street | Apr 8, 2026 | neutral | 0 | 0.6 |
| ENGN Stock Soars On Hopeful Data From Bladder Cancer Study - Stocktwits | ENGN Stock Soars On Hopeful Data From Bladder Cancer Study Stocktwits | View source ↗ | Stocktwits | Mar 5, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.